Laminar Pharma
$9.7M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Laminar Pharma is currently valued at $168.0M as of November 13, 2024. The company has raised a total of $46.0M in funding.
Capital Efficiency
With a capital efficiency ratio of 3.65x, Laminar Pharma has achieved a valuation that is 3.65 times the total capital raised. This metric indicates strong capital efficiency and effective deployment of investor funds.
Investment Perspective
Laminar Pharma's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Laminar Pharma Worth in 2025?
As of 2025, Laminar Pharma is valued at $168.0M, based on the company's Later Stage VC funding round in November 13, 2024. This valuation positions Laminar Pharma as one of the leading private companies in the sector.
Laminar Pharma Valuation History
Laminar Pharma's funding history demonstrates steady growth and investor confidence.
How Laminar Pharma Valuation is Determined
Private company valuations like Laminar Pharma's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Laminar Pharma Valuation FAQs
Is Laminar Pharma profitable?
Laminar Pharma has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Laminar Pharma's valuation compare to competitors?
Laminar Pharma is valued at $168.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Laminar Pharma IPO?
Laminar Pharma has not announced plans for an initial public offering. Until an IPO, investors can access Laminar Pharma shares through secondary market platforms.